Plasma MicroRNA for Prediction of Hepatocellular Carcinoma - Trial NCT05449847
Access comprehensive clinical trial information for NCT05449847 through Pure Global AI's free database. This phase not specified trial is sponsored by Benha University and is currently Completed. The study focuses on Hepatitis C. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Benha University
Timeline & Enrollment
N/A
May 13, 2021
Mar 20, 2022
Primary Outcome
Relation between MicroRNA and HCV
Summary
100 patients with diagnosed HCV were evaluated by clinical and ultrasound examination and
 were categorized as uncomplicated HCV (n=22) and complicated HCV (n=78). All patients were
 evaluated for hepatosteatosis and liver fibrosis using the computerized hepatorenal index,
 the hepatic steatosis index, aspartate aminotransferase (AST)/platelet count index (APRI) and
 the Fibrosis-4 (FIB-4) scores. Blood samples were obtained for estimation of serum levels of
 liver function tests and plasma levels of microRNA 21 and 126.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05449847
Non-Device Trial